Codiak BioSciences, Inc. Operating Income
Codiak BioSciences, Inc. reported Operating Income of -$21.40 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2022-11-03
- Codiak BioSciences, Inc. operating income (loss) for the quarter ending 2022-09-30 was -$21.40M.
- Codiak BioSciences, Inc. operating income (loss) for the quarter ending 2022-06-30 was -$7.02M.
- Codiak BioSciences, Inc. operating income (loss) for the quarter ending 2022-03-31 was -$8.25M.
- Codiak BioSciences, Inc. operating income (loss) for the quarter ending 2021-12-31 was -$16.64M.
- Codiak BioSciences, Inc. operating income (loss) for fiscal 2021 was -$69.55M.
- Codiak BioSciences, Inc. operating income (loss) for fiscal 2020 was -$90.92M.
- Codiak BioSciences, Inc. operating income (loss) for fiscal 2019 was -$80.15M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$21.40M 10-Q · filed 2022-11-03 | -$28.41M derived: sum of 2 quarters · filed 2022-11-03 | -$36.66M 10-Q · filed 2022-11-03 | -$53.30M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | -$7.02M 10-Q · filed 2022-08-04 | -$15.27M 10-Q · filed 2022-08-04 | -$31.91M derived: sum of 3 quarters · filed 2022-08-04 | -$53.40M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | -$8.25M 10-Q · filed 2022-05-05 | -$24.89M derived: sum of 2 quarters · filed 2022-05-05 | -$46.39M derived: sum of 3 quarters · filed 2022-11-03 | -$67.85M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | -$16.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$38.14M derived: sum of 2 quarters · filed 2022-11-03 | -$59.60M derived: sum of 3 quarters · filed 2022-11-03 | -$69.55M 10-K · filed 2022-03-10 |
| 2021-09-30 | -$21.50M 10-Q · filed 2022-11-03 | -$42.96M derived: sum of 2 quarters · filed 2022-11-03 | -$52.91M 10-Q · filed 2022-11-03 | -$70.52M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$21.47M 10-Q · filed 2022-08-04 | -$31.41M 10-Q · filed 2022-08-04 | -$49.02M derived: sum of 3 quarters · filed 2022-08-04 | -$84.05M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$9.95M 10-Q · filed 2022-05-05 | -$27.55M derived: sum of 2 quarters · filed 2022-05-05 | -$62.58M derived: sum of 3 quarters · filed 2022-05-05 | -$78.38M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$17.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$52.63M derived: sum of 2 quarters · filed 2022-03-10 | -$68.43M derived: sum of 3 quarters · filed 2022-03-10 | -$90.92M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$35.03M 10-Q · filed 2021-11-04 | -$50.82M derived: sum of 2 quarters · filed 2021-11-04 | -$73.31M 10-Q · filed 2021-11-04 | -$95.12M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$15.79M 10-Q · filed 2021-08-05 | -$38.28M 10-Q · filed 2021-08-05 | -$60.09M derived: sum of 3 quarters · filed 2021-08-05 | -$81.32M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$22.49M 10-Q · filed 2021-05-06 | -$44.30M derived: sum of 2 quarters · filed 2021-05-06 | -$65.53M derived: sum of 3 quarters · filed 2021-05-06 | |
| 2019-12-31 | -$21.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | -$43.04M derived: sum of 2 quarters · filed 2021-03-17 | -$80.15M 10-K · filed 2021-03-17 | |
| 2019-09-30 | -$21.23M 10-Q · filed 2020-11-19 | -$58.34M 10-Q · filed 2020-11-19 |